Merck Sharp & Dohme LLC v. Halozyme, Inc. et al.

PGR2025-00003

Merck has filed a post‑grant review petition challenging Halozyme’s U.S. Pat. 11,952,600, arguing that the claims lack written description, are not enabled, and are obvious over prior art.

Jurisdiction
US PTAB
Case Number
PGR2025-00003
Decision Date
11 December 2024
Filing Date
11 December 2024

Detailed Summary

In a petition for post‑grant review (PGR2025‑00003), Merck Sharp & Dohme LLC challenges Halozyme’s patent covering engineered human PH20 hyaluronidase proteins. Merck asserts that claims 1‑21 are unpatentable because the specification fails to provide a sufficient written description or enablement for the enormous genus of multiply‑mutated PH20 variants, relying only on single‑mutation examples and a prophetic research plan. Additionally, Merck contends that the D320K mutant claimed in the independent claims would have been obvious to a skilled artisan in 2011 based on Halozyme’s own ’429 patent and the Chao 2007 article, rendering those claims unpatentable under § 103. The petition seeks institution of the PGR and cancellation of all challenged claims.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Merck Sharp & Dohme LLC vs Halozyme, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-01163

Tommy John, Inc.vsPakage Apparel, Inc.

Tommy John, Inc. challenged U.S. Patent No. 10,834,974 held by Pakage Apparel, Inc., asserting that the claims are obvious over prior art references Kitsch and Brocks. The petitioner argues that combining elements from these references in the men's underwear/genital support garment field renders all challenged claims unpatentable.

patentIPR2024-00340

SHENZHEN PINCAN TECHNOLOGY CO., LTDvsThe Ridge Wallet LLC

Shenzhen Pincan Technology filed an IPR challenging The Ridge Wallet's compact wallet patents, asserting that the claims are obvious under 35 U.S.C. § 103. The petition targets all 24 claims using extensive prior art combinations involving references like Kane, Beckley, and Minn.

patentIPR2026-00099

Google LLCvsSecure Communication Technologies, LLC

Google has filed an IPR petition challenging Secure Communication Technologies' ’129 patent, asserting that the claims are anticipated and obvious over the Eagle prior art. The petition seeks institution of the trial and cancellation of fifteen claims.

patentIPR2025-01073

Light & Wonder, Inc. et al.vsEvolution Malta Limited

Light & Wonder has filed an IPR petition challenging Evolution Malta’s ’024 roulette‑payout patent, asserting anticipation and obviousness over Kido, Yee, and Baron prior art.

patentIPR2025-01499

BOE Technology Group Co., Ltd.vsSamsung Display Co., Ltd.

BOE Technology and Samsung Display have settled all disputes in IPR2025-01499 concerning U.S. Patent 9,299,730. They jointly filed a motion to terminate the inter partes review under 35 U.S.C. § 317, citing that the Board has not decided the merits and that settlement serves public policy interests.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call